|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease显示文摘 | Sunder Mudaliar Robert R. Henry Arun J. Sanyal Linda Morrow Hanns-Ulrich Marschall Mark Kipnes Luciano Adorini Cathi I. Sciacca Paul Clopton Erin Castelloe Paul Dillon Mark Pruzanski David Shapiro | 2013 | Gastroenterology2013，，： | 7 |
| 2 | Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes 显示文摘 | Aschner P Kipnes MS Lunceford JK | 2006 | Diabetes Care2006，29，12： | 1 |
| 3 | Effect of the dipeptidyl peptidase-4 inhibitor Sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes 显示文摘 | Aschner P Kipnes MS Lunceford JK | 2006 | Diabetes Care2006，29，12： | 1 |
| 4 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in pa- tients with type 2 diabetes mellitus inadequately con- trolled glimepiride alone or on glimepiride and mefformin 显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 5 | Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitns: a randomized, placebocontrolled study显示文摘 | Kipnes MS Krosnick A Rendell MS Egan JW Mathisen AL Schneider RL | | Am J0，，： | 1 |
| 6 | Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes显示文摘 | Aschner P Kipnes MS Lunceford JK | 2006 | Diabetes care2006，29，12： | 1 |
| 7 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glybufide monotherapy 显示文摘 | Pratley RE Kipnes MS Fleck PR | 2009 | Diabetes Obes Metab2009，11，2： | 1 |
| 8 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or in combination with metformin显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 9 | Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic controll in patients with type 2 diabets mellitus: a randomized,placebo-controlled study显示文摘 | Kipnes MS Krosnick A Rendell MS | 2001 | Am J Med2001，111，： | 1 |
| 10 | Pioglitazone hydrochloride in combination with type 2 diabetes mellitus: a randomized, placebo-controlled study显示文摘 | KIPNES M S KROSNICK A RENDELL M S | 2001 | Am J Med2001，111，： | 1 |
| 11 | Year two assessment of fenofibric acid and moderate-dose statin combination:a phase3,open-label,extension study显示文摘 | Kipnes MS Roth EM Rhyne JM | 2010 | Clin Drug Investig2010，30，1： | 1 |
| 12 | Effieaey and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin,in pa-tients with type 2 diabetes mellitus inadequately con- trolled on glimepiride alone or on glimepiride and met- formin显示文摘 | Hermansen K Kipnes M Luo E et d | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 13 | Effect of the dipeptidyl peptidase-f inhibitor sitagliptin as monotherapy on glycemic control in patients woth type 2 diabetes显示文摘 | Aschner P Kipnes MS Lunceford JK | 2006 | Diabetes Care2006，29，12： | 1 |
| 14 | Safety and pharmacody- namics of CJC-1134-PC, a novel GLP-1 receptor agonist,in pa- tients with type 2 diabetes mellitus : a randomized, Placebo-Con-trolled ; Double-Blind, Dose-Escalation study 显示文摘 | Wang M Kipnes M Matheson S | 2007 | Diabetes2007，56，1： | 1 |
| 15 | Efficacy and safety of the dipel):tidylpeptidase-4 inhibitor,sitagliptin,inpatients with type 2 diabetes mellitue inadequately controlled on glimepiridealone or on glimepiride and metformin显示文摘 | Hermansen K Kipnes M Luo E et at | 2007 | DiabetesObesMetab2007，9，5： | 1 |
| 16 | Dapagliflozin: an emerging treatment option in type 2 diabetes显示文摘 | Kipnes M | 2009 | Expert Opin Investig Drugs2009，18，3： | 1 |
| 17 | Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus; a randomized, placebo - controlled study 显示文摘 | Kipnes M Krosnick A Rendell M | 2001 | Am J Med2001，111，： | 1 |
| 18 | Biological defense mechanisms:the production by leukocytes of superoxide,a potential bactericidal agent显示文摘 | Babior B M Kipnes R S Curnutte J T | 1973 | J Clin Invest1973，52，： | 1 |
| 19 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin,in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin显示文摘 | Hermansen K Kipnes M Luo E | 2007 | Diabetes Obes Metab2007，9，5： | 1 |
| 20 | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor,sitagliptin,in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin显示文摘 | HERMANSEN K KIPNES M LUO E | | 0，，05： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员